KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Alnylam Pharmaceuticals (ALNY) over the last 8 years, with Q3 2025 value amounting to 0.03.

  • Alnylam Pharmaceuticals' Debt Ratio changed N/A to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year change of. This contributed to the annual value of 0.02 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Alnylam Pharmaceuticals' Debt Ratio is 0.03.
  • Alnylam Pharmaceuticals' 5-year Debt Ratio high stood at 0.19 for Q4 2021, and its period low was 0.02 during Q4 2024.
  • For the 3-year period, Alnylam Pharmaceuticals' Debt Ratio averaged around 0.06, with its median value being 0.03 (2025).
  • Within the past 5 years, the most significant YoY rise in Alnylam Pharmaceuticals' Debt Ratio was 23034.78% (2021), while the steepest drop was 23034.78% (2021).
  • Quarter analysis of 3 years shows Alnylam Pharmaceuticals' Debt Ratio stood at 0.19 in 2021, then tumbled by 88.07% to 0.02 in 2024, then grew by 13.01% to 0.03 in 2025.
  • Its Debt Ratio stands at 0.03 for Q3 2025, versus 0.03 for Q2 2025 and 0.03 for Q1 2025.